COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 208 filers reported holding COHERUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,900 | +66.1% | 83,329 | +90.9% | 0.00% | – |
| Q2 2023 | $188,393 | -40.3% | 43,660 | -6.2% | 0.00% | – |
| Q1 2023 | $315,471 | -7.1% | 46,564 | +3.3% | 0.00% | – |
| Q4 2022 | $339,570 | +147.9% | 45,095 | +227.8% | 0.00% | – |
| Q3 2022 | $137,000 | -62.3% | 13,756 | -72.1% | 0.00% | -100.0% |
| Q2 2022 | $363,000 | -19.2% | 49,358 | +44.5% | 0.00% | 0.0% |
| Q1 2022 | $449,000 | +205.4% | 34,153 | +223.5% | 0.00% | – |
| Q2 2021 | $147,000 | -45.4% | 10,556 | -31.7% | 0.00% | – |
| Q4 2020 | $269,000 | +17.0% | 15,446 | +20.0% | 0.00% | – |
| Q2 2020 | $230,000 | -11.2% | 12,871 | -20.3% | 0.00% | -100.0% |
| Q1 2020 | $259,000 | +42.3% | 16,157 | +59.8% | 0.00% | – |
| Q4 2019 | $182,000 | -46.2% | 10,113 | -39.3% | 0.00% | -100.0% |
| Q3 2019 | $338,000 | – | 16,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |